Chargement en cours...
Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma
Metastatic disease in a cancer patient still remains a therapeutic challenge. Metastatic process involves many steps, during which malignant cells succeed to activate cellular pathways promoting survival in hostile environment, engraftment and growth at the distant site from the primary tumor. Melan...
Enregistré dans:
| Publié dans: | Mol Cancer |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5817811/ https://ncbi.nlm.nih.gov/pubmed/29455657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-018-0795-z |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|